Mirko Farina

2.7k total citations · 1 hit paper
75 papers, 1.6k citations indexed

About

Mirko Farina is a scholar working on Hematology, Genetics and Computational Theory and Mathematics. According to data from OpenAlex, Mirko Farina has authored 75 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 24 papers in Genetics and 12 papers in Computational Theory and Mathematics. Recurrent topics in Mirko Farina's work include Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Mirko Farina is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers). Mirko Farina collaborates with scholars based in Italy, United States and France. Mirko Farina's co-authors include P. Amato, Kalyanmoy Deb, Simona Bernardi, J.K. Sykulski, Michele Malagola, Nicola Polverelli, Paolo Di Barba, Domenico Russo, A. Savini and Federica Re and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer.

In The Last Decade

Mirko Farina

67 papers receiving 1.5k citations

Hit Papers

Dynamic Multiobjective Optimization Problems: Test Cases,... 2004 2026 2011 2018 2004 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirko Farina Italy 16 827 714 268 166 164 75 1.6k
Bhaskar DasGupta United States 27 214 0.3× 236 0.3× 201 0.8× 259 1.6× 63 0.4× 121 2.3k
David S. Matheson Canada 17 150 0.2× 244 0.3× 121 0.5× 29 0.2× 77 0.5× 42 1.0k
Maurizio Martelli Italy 33 289 0.3× 508 0.7× 311 1.2× 916 5.5× 6 0.0× 203 4.4k
RA Miller United States 12 199 0.2× 77 0.1× 57 0.2× 107 0.6× 93 0.6× 26 1.0k
Xuzhu Wang China 14 210 0.3× 292 0.4× 41 0.2× 31 0.2× 942 5.7× 34 1.8k
Zhigang Gao China 20 39 0.0× 286 0.4× 156 0.6× 159 1.0× 21 0.1× 115 1.6k
Luc Boullart Belgium 14 56 0.1× 227 0.3× 72 0.3× 29 0.2× 52 0.3× 53 835
Michela Antonelli Italy 21 134 0.2× 596 0.8× 32 0.1× 9 0.1× 110 0.7× 55 1.1k
Zhifang Pan China 32 341 0.4× 1.3k 1.8× 7 0.0× 15 0.1× 41 0.3× 92 3.0k
Sonal Jain India 20 23 0.0× 279 0.4× 34 0.1× 49 0.3× 108 0.7× 83 1.4k

Countries citing papers authored by Mirko Farina

Since Specialization
Citations

This map shows the geographic impact of Mirko Farina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirko Farina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirko Farina more than expected).

Fields of papers citing papers by Mirko Farina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirko Farina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirko Farina. The network helps show where Mirko Farina may publish in the future.

Co-authorship network of co-authors of Mirko Farina

This figure shows the co-authorship network connecting the top 25 collaborators of Mirko Farina. A scholar is included among the top collaborators of Mirko Farina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirko Farina. Mirko Farina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farina, Mirko, Michele Malagola, Simona Bernardi, et al.. (2025). Intensive Chemotherapy Versus Venetoclax-Based Regimens in Elderly Patients with Acute Myeloid Leukemia: Is the Chemotherapy Era Ending?. Journal of Clinical Medicine. 14(8). 2759–2759. 1 indexed citations
2.
Ferraro, Rosalba Monica, Elena Laura Mazzoldi, Mirko Farina, et al.. (2025). Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent. Cell Biology International. 49(5). 570–586. 4 indexed citations
3.
Palandri, Francesca, Massimo Breccia, Elena Maria Elli, et al.. (2025). Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea. Leukemia. 39(8). 1928–1936.
4.
Federici, Stefania, Lucia Paolini, Cristian Bonvicini, et al.. (2025). Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular Vesicles. Journal of Cellular and Molecular Medicine. 29(20). e70901–e70901.
5.
Re, Federica, Luciana Sartore, Matteo Ferroni, et al.. (2024). In Vitro Biocompatibility Assessment of Bioengineered PLA-Hydrogel Core–Shell Scaffolds with Mesenchymal Stromal Cells for Bone Regeneration. Journal of Functional Biomaterials. 15(8). 217–217.
7.
Morello, Enrico, Liana Signorini, Simona Bernardi, et al.. (2024). Nutritional Strategies To Improve VRE Control. Transplantation and Cellular Therapy. 30(5). 548.e1–548.e4. 2 indexed citations
8.
Bernardi, Simona, Mirko Farina, Cristina Bucelli, et al.. (2024). Digital PCR (dPCR) is able to anticipate the achievement of stable deep molecular response in adult chronic myeloid leukemia patients: results of the DEMONSTRATE study. Annals of Hematology. 104(1). 207–217. 5 indexed citations
9.
Barone, Angelica, Annalisa Chiappella, Beatrice Casadei, et al.. (2024). Secondary primary malignancies after CD‐19 directed CAR‐T‐cell therapy in lymphomas: A report from the Italian CARTSIE study. British Journal of Haematology. 205(4). 1356–1360. 3 indexed citations
10.
Farina, Mirko, Luisa Lorenzi, Nicola Polverelli, et al.. (2023). High risk-myelodysplastic syndrome following CAR T-cell therapy in a patient with relapsed diffuse large B cell lymphoma: A case report and literature review. Frontiers in Oncology. 13. 1036455–1036455. 7 indexed citations
11.
Polverelli, Nicola, Mirko Farina, Mariella D’Adda, et al.. (2022). How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation. Cells. 11(3). 553–553. 9 indexed citations
12.
Malagola, Michele, Alessandro Turra, Liana Signorini, et al.. (2022). Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol). Frontiers in Oncology. 12. 874117–874117. 9 indexed citations
13.
Zizioli, Daniela, Simona Bernardi, Mirko Farina, et al.. (2021). Development of BCR-ABL1 Transgenic Zebrafish Model Reproducing Chronic Myeloid Leukemia (CML) Like-Disease and Providing a New Insight into CML Mechanisms. Cells. 10(2). 445–445. 6 indexed citations
14.
Farina, Mirko, Domenico Russo, & Ronald Hoffman. (2021). The possible role of mutated endothelial cells in myeloproliferative neoplasms. Haematologica. 106(11). 2813–2823. 11 indexed citations
15.
Bernardi, Simona, Mirko Farina, Federica Cattina, et al.. (2020). ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial. SHILAP Revista de lepidopterología. 2020. 1–7. 6 indexed citations
16.
Dunbar, Andrew, Kelly L. Bolton, Sean M. Devlin, et al.. (2020). Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors. Blood. 137(15). 2103–2113. 66 indexed citations
17.
Malagola, Michele, Nicola Polverelli, Valeria Cancelli, et al.. (2019). Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner?. SHILAP Revista de lepidopterología. 2019. 1–4. 1 indexed citations
20.
Farina, Mirko, A. Bramanti, & Paolo Di Barba. (2002). GRS method for Pareto-optimal front identification in electromagnetic synthesis. IEE Proceedings - Science Measurement and Technology. 149(5). 207–213. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026